Trials / Completed
CompletedNCT00136799
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 325 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluvastatin |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2006-04-01
- Completion
- 2006-04-01
- First posted
- 2005-08-29
- Last updated
- 2017-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00136799. Inclusion in this directory is not an endorsement.